関連レポート

出版元：QY Research  出版元について

発行年：2024年12月

定価：Single User License $2900 Multi User License $4350 Enterprise License $5800

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 137ページになります。

商品コード：QYR124

レポート紹介

ウイルスおよび非ウイルス性ベクターの世界市場は、2023年5億5185万ドルから2030年には35億500万ドルに成長し、予測期間中の年間平均成長率（CAGR）は31.84％と予測されています。

当レポートでは、 ウイルスおよび非ウイルス性ベクターの市場予測-2030年、各種セグメント別市場分析(タイプ別、用途別、国地域別、等)、企業別分析などの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■ウイルスおよび非ウイルス性ベクターの世界市場予測2024-2030年
・市場規模(US$)

■企業別分析
Thermo Fisher Scientific
Lonza
Azenta Life Sciences
Revvity
VectorBuilder
タカラバイオ株式会社
GenScript Biotech
Gene Chem
Geno Meditech
PackGene Biotech
VIROVEK
OriGen
Vector BioLabs

■タイプ別市場
アデノ随伴ウイルス（AAV）
レンチウイルス
レトロウイルス
アデノウイルス
DNAプラスミド
その他

■用途別市場
製薬、バイオ医薬品企業
学術、研究機関
その他
■国地域別市場
北米
・米国
・カナダ
・メキシコ
アジア太平洋
・中国
・日本
・韓国
・東南アジア
・インド
・オーストラリア
・その他アジア
ヨーロッパ
・ドイツ
・フランス
・英国
・イタリア
・ロシア
・その他欧州
南米
・ブラジル
・その他南米
（全137頁）

Table of Contents (英文詳細目次）

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1
1.2.2 AAV 4
1.2.3 Lentiviruses 4
1.2.4 Retroviruses 5
1.2.5 Adenoviruses 5
1.2.6 DNA Plasmids 6
1.3 Market by Application 6
1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2019 VS 2023 VS 2030 7
1.3.2 Pharmaceutical and Biopharmaceutical Companies 9
1.3.3 Academics and Research Institutes 10
1.4 Assumptions and Limitations 11
1.5 Study Objectives 12
1.6 Years Considered 13

2 Global Growth Trends 14
2.1 Global Viral and Non-viral Vector Market Perspective (2019-2030) 14
2.2 Global Viral and Non-viral Vector Growth Trends by Region 15
2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2019 VS 2023 VS 2030 16
2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2019-2024) 18
2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030) 19
2.3 Viral and Non-viral Vector Market Dynamics 19
2.3.1 Viral and Non-viral Vector Industry Trends 19
2.3.2 Viral and Non-viral Vector Market Drivers 21
2.3.3 Viral and Non-viral Vector Market Challenges 22
2.3.4 Viral and Non-viral Vector Market Restraints 23

3 Competition Landscape by Key Players 24
3.1 Global Top Viral and Non-viral Vector Players by Revenue 24
3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2019-2024) 24
3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2019-2024) 25
3.2 Global Viral and Non-viral Vector Market by Company Type (Tier 1, Tier 2, and Tier 3) 26
3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue 27
3.4 Global Viral and Non-viral Vector Market Concentration Ratio 28
3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2023 29
3.5 Global Key Players of Viral and Non-viral Vector Head office and Area Served 30
3.6 Global Key Players of Viral and Non-viral Vector, Product 31
3.7 Global Key Players of Viral and Non-viral Vector, Founded Date 31
3.8 Mergers & Acquisitions, Expansion Plans 32

4 Viral and Non-viral Vector Breakdown Data by Type 34
4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2019-2024) 34
4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030) 35

5 Viral and Non-viral Vector Breakdown Data by Application 36
5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2019-2024) 36
5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030) 37

6 North America 38
6.1 North America Viral and Non-viral Vector Market Size (2019-2030) 38
6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030 38
6.3 North America Viral and Non-viral Vector Market Size by Country (2019-2024) 39
6.4 North America Viral and Non-viral Vector Market Size by Country (2025-2030) 39
6.5 United States 40
6.6 Canada 41
6.7 Mexico 42

7 Europe 43
7.1 Europe Viral and Non-viral Vector Market Size (2019-2030) 43
7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030 43
7.3 Europe Viral and Non-viral Vector Market Size by Country (2019-2024) 44
7.4 Europe Viral and Non-viral Vector Market Size by Country (2025-2030) 44
7.5 Germany 45
7.6 France 46
7.7 U.K. 46
7.8 Italy 47
7.9 Russia 47
7.10 Spain 48

8 Asia-Pacific 49
8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2019-2030) 49
8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030 49
8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024) 50
8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030) 50
8.5 China 52
8.6 Japan 52
8.7 South Korea 53
8.8 Southeast Asia 53
8.9 India 54
8.10 Australia 54

9 South America 55
9.1 South America Viral and Non-viral Vector Market Size (2019-2030) 55
9.2 South America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030 55
9.3 South America Viral and Non-viral Vector Market Size by Country (2019-2024) 56
9.4 South America Viral and Non-viral Vector Market Size by Country (2025-2030) 56
9.5 Brazil 57

10 Middle East & Africa 58
10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2019-2030) 58
10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030 58
10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024) 59
10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030) 59
10.5 Middle East 60
10.6 Africa 61

11 Key Players Profiles 62
11.1 Thermo Fisher Scientific 62
11.1.1 Thermo Fisher Scientific Company Details 62
11.1.2 Thermo Fisher Scientific Business Overview 62
11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction 63
11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024) 64
11.1.5 Thermo Fisher Scientific Recent Development 64
11.2 Lonza 65
11.2.1 Lonza Company Details 65
11.2.2 Lonza Business Overview 66
11.2.3 Lonza Viral and Non-viral Vector Introduction 66
11.2.4 Lonza Revenue in Viral and Non-viral Vector Business (2019-2024) 68
11.2.5 Lonza Recent Development 68
11.3 Azenta Life Sciences 69
11.3.1 Azenta Life Sciences Company Details 69
11.3.2 Azenta Life Sciences Business Overview 70
11.3.3 Azenta Life Sciences Viral and Non-viral Vector Introduction 70
11.3.4 Azenta Life Sciences Revenue in Viral and Non-viral Vector Business (2019-2024) 71
11.3.5 Azenta Life Sciences Recent Development 72
11.4 Revvity 73
11.4.1 Revvity Company Details 73
11.4.2 Revvity Business Overview 73
11.4.3 Revvity Viral and Non-viral Vector Introduction 74
11.4.4 Revvity Revenue in Viral and Non-viral Vector Business (2019-2024) 76
11.5 VectorBuilder 76
11.5.1 VectorBuilder Company Details 76
11.5.2 VectorBuilder Business Overview 77
11.5.3 VectorBuilder Viral and Non-viral Vector Introduction 77
11.5.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024) 79
11.5.5 VectorBuilder Recent Development 80
11.6 Takara Bio 81
11.6.1 Takara Bio Company Details 81
11.6.2 Takara Bio Business Overview 81
11.6.3 Takara Bio Viral and Non-viral Vector Introduction 82
11.6.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024) 86
11.6.5 Takara Bio Recent Development 86
11.7 GenScript Biotech 88
11.7.1 GenScript Biotech Company Details 88
11.7.2 GenScript Biotech Business Overview 89
11.7.3 GenScript Biotech Viral and Non-viral Vector Introduction 89
11.7.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) 90
11.7.5 GenScript Biotech Recent Development 91
11.8 Gene Chem 92
11.8.1 Gene Chem Company Details 92
11.8.2 Gene Chem Business Overview 92
11.8.3 Gene Chem Viral and Non-viral Vector Introduction 93
11.8.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024) 94
11.9 Geno Meditech 94
11.9.1 Geno Meditech Company Details 95
11.9.2 Geno Meditech Business Overview 95
11.9.3 Geno Meditech Viral and Non-viral Vector Introduction 96
11.9.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024) 97
11.10 PackGene Biotech 98
11.10.1 PackGene Biotech Company Details 98
11.10.2 PackGene Biotech Business Overview 99
11.10.3 PackGene Biotech Viral and Non-viral Vector Introduction 99
11.10.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) 100
11.11 VIROVEK 101
11.11.1 VIROVEK Company Details 101
11.11.2 VIROVEK Business Overview 102
11.11.3 VIROVEK Viral and Non-viral Vector Introduction 102
11.11.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024) 103
11.11.5 VIROVEK Recent Development 104
11.12 OriGen 104
11.12.1 OriGen Company Details 104
11.12.2 OriGen Business Overview 105
11.12.3 OriGen Viral and Non-viral Vector Introduction 105
11.12.4 OriGen Revenue in Viral and Non-viral Vector Business (2019-2024) 106
11.13 Vector BioLabs 107
11.13.1 Vector BioLabs Company Details 107
11.13.2 Vector BioLabs Business Overview 108
11.13.3 Vector BioLabs Viral and Non-viral Vector Introduction 108
11.13.4 Vector BioLabs Revenue in Viral and Non-viral Vector Business (2019-2024) 109
11.13.5 Vector BioLabs Recent Development 110

12 Analyst's Viewpoints/Conclusions 111

13 Appendix 113
13.1 Research Methodology 113
13.1.1 Methodology/Research Approach 113
13.1.2 Data Source 116
13.2 Author Details 119
13.3 Disclaimer 119

Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 1
Table 2. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 7
Table 3. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 16
Table 4. Global Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million) 18
Table 5. Global Viral and Non-viral Vector Market Share by Region (2019-2024) 18
Table 6. Global Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030) & (US$ Million) 19
Table 7. Global Viral and Non-viral Vector Market Share by Region (2025-2030) 19
Table 8. Viral and Non-viral Vector Market Trends 19
Table 9. Viral and Non-viral Vector Market Drivers 21
Table 10. Viral and Non-viral Vector Market Challenges 22
Table 11. Viral and Non-viral Vector Market Restraints 23
Table 12. Global Viral and Non-viral Vector Revenue by Players (2019-2024) & (US$ Million) 24
Table 13. Global Viral and Non-viral Vector Market Share by Players (2019-2024) 25
Table 14. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2023) 26
Table 15. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2023 27
Table 16. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI) & (2019-2024) 29
Table 17. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served 30
Table 18. Global Key Players of Viral and Non-viral Vector, Product 31
Table 19. Global Key Players of Viral and Non-viral Vector, Founded Date 31
Table 20. Mergers & Acquisitions, Expansion Plans 32
Table 21. Global Viral and Non-viral Vector Market Size by Type (2019-2024) & (US$ Million) 34
Table 22. Global Viral and Non-viral Vector Revenue Market Share by Type (2019-2024) 34
Table 23. Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030) & (US$ Million) 35
Table 24. Global Viral and Non-viral Vector Revenue Market Share by Type (2025-2030) 35
Table 25. Global Viral and Non-viral Vector Market Size by Application (2019-2024) & (US$ Million) 36
Table 26. Global Viral and Non-viral Vector Revenue Market Share by Application (2019-2024) 36
Table 27. Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030) & (US$ Million) 37
Table 28. Global Viral and Non-viral Vector Revenue Market Share by Application (2025-2030) 37
Table 29. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 38
Table 30. North America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million) 39
Table 31. North America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million) 39
Table 32. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 43
Table 33. Europe Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million) 44
Table 34. Europe Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million) 44
Table 35. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 49
Table 36. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million) 50
Table 37. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030) & (US$ Million) 50
Table 38. South America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 55
Table 39. South America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million) 56
Table 40. South America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million) 56
Table 41. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 58
Table 42. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million) 59
Table 43. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million) 59
Table 44. Thermo Fisher Scientific Company Details 62
Table 45. Thermo Fisher Scientific Business Overview 62
Table 46. Thermo Fisher Scientific Viral and Non-viral Vector Product 63
Table 47. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 64
Table 48. Thermo Fisher Scientific Recent Development 64
Table 49. Lonza Company Details 65
Table 50. Lonza Business Overview 66
Table 51. Lonza Viral and Non-viral Vector Product 66
Table 52. Lonza Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 68
Table 53. Lonza Recent Development 68
Table 54. Azenta Life Sciences Company Details 69
Table 55. Azenta Life Sciences Business Overview 70
Table 56. Azenta Life Sciences Viral and Non-viral Vector Product 70
Table 57. Azenta Life Sciences Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 71
Table 58. Azenta Life Sciences Recent Development 72
Table 59. Revvity Company Details 73
Table 60. Revvity Business Overview 73
Table 61. Revvity Viral and Non-viral Vector Product 74
Table 62. Revvity Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 76
Table 63. VectorBuilder Company Details 76
Table 64. VectorBuilder Business Overview 77
Table 65. VectorBuilder Viral and Non-viral Vector Product 77
Table 66. VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 79
Table 67. VectorBuilder Recent Development 80
Table 68. Takara Bio Company Details 81
Table 69. Takara Bio Business Overview 81
Table 70. Takara Bio Viral and Non-viral Vector Product 82
Table 71. Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 86
Table 72. Takara Bio Recent Development 86
Table 73. GenScript Biotech Company Details 88
Table 74. GenScript Biotech Business Overview 89
Table 75. GenScript Biotech Viral and Non-viral Vector Product 89
Table 76. GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 90
Table 77. GenScript Biotech Recent Development 91
Table 78. Gene Chem Company Details 92
Table 79. Gene Chem Business Overview 92
Table 80. Gene Chem Viral and Non-viral Vector Product 93
Table 81. Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 94
Table 82. Geno Meditech Company Details 95
Table 83. Geno Meditech Business Overview 95
Table 84. Geno Meditech Viral and Non-viral Vector Product 96
Table 85. Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 97
Table 86. PackGene Biotech Company Details 98
Table 87. PackGene Biotech Business Overview 99
Table 88. PackGene Biotech Viral and Non-viral Vector Product 99
Table 89. PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 100
Table 90. VIROVEK Company Details 101
Table 91. VIROVEK Business Overview 102
Table 92. VIROVEK Viral and Non-viral Vector Product 102
Table 93. VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 103
Table 94. VIROVEK Recent Development 104
Table 95. OriGen Company Details 104
Table 96. OriGen Business Overview 105
Table 97. OriGen Viral and Non-viral Vector Product 105
Table 98. OriGen Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 106
Table 99. Vector BioLabs Company Details 107
Table 100. Vector BioLabs Business Overview 108
Table 101. Vector BioLabs Viral and Non-viral Vector Product 108
Table 102. Vector BioLabs Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million) 109
Table 103. Vector BioLabs Recent Development 110
Table 104. Research Programs/Design for This Report 113
Table 105. Key Data Information from Secondary Sources 117
Table 106. Key Data Information from Primary Sources 118
Table 107. Authors List of This Report 119

List of Figures

Figure 1. Global Viral and Non-viral Vector Market Size Comparison by Type (2024-2030) & (US$ Million) 2
Figure 2. Global Viral and Non-viral Vector Market Share by Type: 2023 3
Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2030 3
Figure 4. AAV Features 4
Figure 5. Global Viral and Non-viral Vector Market Size by Application (2024-2030) & (US$ Million) 8
Figure 6. Global Viral and Non-viral Vector Market Share by Application: 2023 9
Figure 7. Global Viral and Non-viral Vector Market Share by Application: 2030 9
Figure 8. Pharmaceutical and Biopharmaceutical Companies Case Studies 10
Figure 9. Academics and Research Institutes Case Studies 11
Figure 10. Viral and Non-viral Vector Report Years Considered 13
Figure 11. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2019-2030 14
Figure 12. Global Viral and Non-viral Vector Market Size, (US$ Million), 2019 VS 2024 VS 2030 15
Figure 13. Global Viral and Non-viral Vector Market Share by Region: 2023 17
Figure 14. Global Viral and Non-viral Vector Market Share by Region: 2030 18
Figure 15. Global Viral and Non-viral Vector Market Share by Players in 2023 26
Figure 16. The Top 5 Players Market Share by Viral and Non-viral Vector Revenue in 2023 29
Figure 17. The Top 10 Players Market Share by Viral and Non-viral Vector Revenue in 2023 30
Figure 18. North America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 38
Figure 19. North America Viral and Non-viral Vector Market Share by Country (2019-2030) 40
Figure 20. United States Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 40
Figure 21. Canada Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 41
Figure 22. Mexico Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 42
Figure 23. Europe Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 43
Figure 24. Europe Viral and Non-viral Vector Market Share by Country (2019-2030) 45
Figure 25. Germany Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 45
Figure 26. France Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 46
Figure 27. U.K. Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 46
Figure 28. Italy Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 47
Figure 29. Russia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 47
Figure 30. Spain Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 48
Figure 31. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 49
Figure 32. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2019-2030) 51
Figure 33. China Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 52
Figure 34. Japan Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 52
Figure 35. South Korea Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 53
Figure 36. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 53
Figure 37. India Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 54
Figure 38. Australia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 54
Figure 39. South America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 55
Figure 40. South America Viral and Non-viral Vector Market Share by Country (2019-2030) 57
Figure 41. Brazil Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 57
Figure 42. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 58
Figure 43. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2019-2030) 60
Figure 44. Middle East Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 60
Figure 45. Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million) 61
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 64
Figure 47. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 68
Figure 48. Azenta Life Sciences Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 72
Figure 49. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 76
Figure 50. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 80
Figure 51. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 86
Figure 52. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 91
Figure 53. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 94
Figure 54. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 98
Figure 55. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 101
Figure 56. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 103
Figure 57. OriGen Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 107
Figure 58. Vector BioLabs Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024) 110
Figure 59. Bottom-up and Top-down Approaches for This Report 115
Figure 60. Data Triangulation 116
Figure 61. Key Executives Interviewed 118

△ 一番上に戻る